Machine Learning Prediction of Hoehn and Yahr Scores at 5‐Years Post‐ <scp> <sup>123</sup> I </scp> ‐Ioflupane <scp>SPECT</scp> Imaging in a Real‐World Parkinson's Disease Dataset

BACKGROUND: Parkinson's disease (PD) progression is highly heterogeneous, complicating clinical management and prognostication. While machine learning models have been developed using research datasets such as Parkinson's Precision Medicine Initiative (PPMI) and Parkinson's Disease Biomarkers Program (PDBP), their clinical translatability is limited due to differences in routinely collected data. The Hoehn and Yahr (H&Y) scale is commonly used in clinical practice to stage PD, yet most predictive models focus on less practical measures. OBJECTIVES: This study developed and validated machine learning models to predict H&Y scores at 5 years post-123I-ioflupane single-photon emission computed tomography (SPECT) imaging, leveraging both a real-world dataset and a subset of the PPMI cohort. The goal was to assess the utility of routinely collected clinical and imaging data for prognostic modeling. METHODS: Data from medical records and imaging were harmonized from 343 real-world patients and 134 PPMI patients, resulting in a merged dataset with 83 overlapping features. Random Forest and Gradient Boosting models were trained to predict 5-year H&Y scores using varying amounts of longitudinal data and imaging features. RESULTS: Models using 2 years of clinical follow-up data achieved the highest predictive accuracy. The most important predictors were early H&Y scores, gait symptom severity, and select imaging features. CONCLUSIONS: Machine learning models can predict 5-year H&Y scores in PD using real-world clinical data, but imaging features add limited prognostic value. This study demonstrated that implementing machine learning models, when using real-world data, did not significantly improve the already known gap between prognostic modeling and real-world implementation. Improvement of models is, however, a promising prospect and further studies are encouraged.

Authors

Institutions

Publication Details

Journal
Movement Disorders Clinical Practice
Published
2026-07-25
DOI
https://doi.org/10.1002/mdc3.70749
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Machine Learning Prediction of Hoehn and Yahr Scores at 5‐Years Post‐ 123 I ‐Ioflupane SPECT Imaging in a Real‐World Parkinson's Disease Dataset

Renee Miller, Balázs Laczi, Michael Zaucha Sørensen, Markus Nowak Lonsdale et al.
Movement Disorders Clinical Practice
Parkinson's Disease Mechanisms and Treatments
article

Machine Learning Prediction of Hoehn and Yahr Scores at 5‐Years Post‐ 123 I ‐Ioflupane SPECT Imaging in a Real‐World Parkinson's Disease Dataset

Renee Miller, Balázs Laczi, Michael Zaucha Sørensen, Markus Nowak Lonsdale, M Johansen, Annemette Løkkegaard, Xuehua Ye, Jan Wolber, Mads Peter Horndrup, Rasmus Vestergård Madsen
article en

Abstract

BACKGROUND: Parkinson's disease (PD) progression is highly heterogeneous, complicating clinical management and prognostication. While machine learning models have been developed using research datasets such as Parkinson's Precision Medicine Initiative (PPMI) and Parkinson's Disease Biomarkers Program (PDBP), their clinical translatability is limited due to differences in routinely collected data. The Hoehn and Yahr (H&Y) scale is commonly used in clinical practice to stage PD, yet most predictive models focus on less practical measures. OBJECTIVES: This study developed and validated machine learning models to predict H&Y scores at 5 years post-123I-ioflupane single-photon emission computed tomography (SPECT) imaging, leveraging both a real-world dataset and a subset of the PPMI cohort. The goal was to assess the utility of routinely collected clinical and imaging data for prognostic modeling. METHODS: Data from medical records and imaging were harmonized from 343 real-world patients and 134 PPMI patients, resulting in a merged dataset with 83 overlapping features. Random Forest and Gradient Boosting models were trained to predict 5-year H&Y scores using varying amounts of longitudinal data and imaging features. RESULTS: Models using 2 years of clinical follow-up data achieved the highest predictive accuracy. The most important predictors were early H&Y scores, gait symptom severity, and select imaging features. CONCLUSIONS: Machine learning models can predict 5-year H&Y scores in PD using real-world clinical data, but imaging features add limited prognostic value. This study demonstrated that implementing machine learning models, when using real-world data, did not significantly improve the already known gap between prognostic modeling and real-world implementation. Improvement of models is, however, a promising prospect and further studies are encouraged.

Movement Disorders Clinical Practice
University of Copenhagen (DK), General Electric (Spain) (ES), Frederiksberg Hospital (DK)
GE Healthcare
Openalex Percentile: Top 8%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.